MCID: FML035
MIFTS: 55

Familial Hyperlipidemia malady

Genetic diseases, Rare diseases, Endocrine diseases categories
Download this MalaCard

Summaries for Familial Hyperlipidemia

About this section
Sources:
33MalaCards
See all sources

Fully expand this MalaCard
MalaCards: Familial Hyperlipidemia, also known as familial hyperlipoproteinemia, is related to hyperlipoproteinemia type v and cholestasis. An important gene associated with Familial Hyperlipidemia is USF1 (upstream transcription factor 1), and among its related pathways are Binding and Uptake of Ligands by Scavenger Receptors and PPAR signaling pathway. The drugs fish oils and coenzyme q10 and the compounds psyllium and fenofibric acid have been mentioned in the context of this disorder. Affiliated tissues include heart, and related mouse phenotypes are adipose tissue and liver/biliary system.

Aliases & Classifications for Familial Hyperlipidemia

About this section
Sources:
8Disease Ontology, 10DISEASES, 62UMLS, 58SNOMED-CT, 40NCIt, 35MeSH
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Genetic diseases, Rare diseases
Anatomical: Endocrine diseases


Aliases & Descriptions:

familial hyperlipidemia 8 10
familial hyperlipoproteinemia 8 62
hyperlipidemia 62
hyperlipemia 8


External Ids:

Disease Ontology8 DOID:1168

Related Diseases for Familial Hyperlipidemia

About this section
Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases in the Hyperlipidemia Type 3 family:

familial hyperlipidemia

Diseases related to Familial Hyperlipidemia via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 89)
idRelated DiseaseScoreTop Affiliating Genes
1hyperlipoproteinemia type v30.3LPL, APOC2, APOE
2cholestasis30.0LIPC, CETP, LCAT
3familial combined hyperlipidemia30.0APOE, APOA1, APOB, HMGCR
4familial hypercholesterolemia30.0HMGCR, PCSK9, CETP, LDLR, APOB
5xanthomatosis29.9APOE, APOB, LDLR, LPL
6nephrotic syndrome29.8HMGCR, LCAT, LPL, LPA, CETP, APOB
7hyperlipidemia type 329.6APOA5, APOA1, APOE, APOB, LIPC, LDLR
8diabetes mellitus29.4APOB, APOC2, APOA2, APOA5, APOC3, APOA1
9hypercholesterolemia29.3APOC3, APOA1, APOE, INS, APOA2, APOC2
10hypertriglyceridemia29.3APOA1, APOE, INS, APOC3, APOA5, APOA2
11familial lipoprotein lipase deficiency10.4
12panhypopituitarism10.1
13cerebral atherosclerosis10.1APOA1
14chylomicron retention disease10.1APOB
15hepatic lipase deficiency10.1LIPC
16lipoprotein glomerulopathy10.1APOE
17amyloidosis, renal10.1APOA2, APOA1
18stroke, ischemic10.1COG2, LPA, APOA2
19peripheral vascular disease10.1INS
20sitosterolemia10.1HMGCR
21fish-eye disease10.1APOA1, APOA2, LCAT
22hyperlipoproteinemia type iv10.0
23hyperlipoproteinemia type iii10.0
24hyperlipoproteinemia type 210.0
25hypothyroidism10.0APOB, CETP, LPA
26arcus senilis10.0APOA1, APOB, LCAT
27amyloidosis, secondary10.0APOA1, LPA, LCAT
28alagille syndrome10.0LCAT, LPA, APOA1
29age related macular degeneration10.0APOE, APOB
30stroke, hemorrhagic10.0APOE, HMGCR
31venous thrombosis10.0HMGCR, CETP, APOB
32complete lcat deficiency10.0APOA1, APOA2, LPA, LCAT
33alzheimer disease type 210.0CETP, APOE
34lipase deficiency combined10.0LIPC, LPL
35supravalvular aortic stenosis10.0
36glycogen storage disease10.0
37pyloric stenosis10.0
38pancreatitis, chronic10.0APOC2, APOB, LPL
39hyperthyroidism10.0INS, APOA2, LDLR
40extrahepatic cholestasis10.0
41hyperglobulinemic purpura10.0
42hyperphosphatemia10.0
43shwartzman phenomenon10.0
44lactic acidosis10.0
45myeloma10.0
46purpura10.0
47adrenocortical insufficiency10.0
48endotheliitis10.0
49acute myocardial infarction10.0APOA1, APOB, LPA, LCAT, HMGCR
50hepatoblastoma10.0APOA1, APOA2, APOB, LDLR, HMGCR

Graphical network of the top 20 diseases related to Familial Hyperlipidemia:



Diseases related to familial hyperlipidemia

Symptoms for Familial Hyperlipidemia

About this section

Drugs & Therapeutics for Familial Hyperlipidemia

About this section
Sources:
42NIH Clinical Center, 6ClinicalTrials, 62UMLS, 41NDF-RT
See all sources

Drug clinical trials:

Search ClinicalTrials for Familial Hyperlipidemia

Search NIH Clinical Center for Familial Hyperlipidemia

Inferred drug relations via UMLS62/NDF-RT41:

Genetic Tests for Familial Hyperlipidemia

About this section

Anatomical Context for Familial Hyperlipidemia

About this section
Sources:
33MalaCards
See all sources

MalaCards organs/tissues related to Familial Hyperlipidemia:

33
Heart

Animal Models for Familial Hyperlipidemia or affiliated genes

About this section
Sources:
37MGI
See all sources

MGI Mouse Phenotypes related to Familial Hyperlipidemia:

37
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053757.9LPL, LDLR, APOC3, APOE, INS
2MP:00053706.8INS, APOE, APOA1, APOB, LDLR, LPL
3MP:00053856.6INS, APOE, APOA1, APOC3, APOB, LDLR
4MP:00053765.8PCSK9, INS, APOE, APOA1, APOC3, APOA5

Publications for Familial Hyperlipidemia

About this section
Sources:
52PubMed
See all sources

Articles related to Familial Hyperlipidemia:

(show all 23)
idTitleAuthorsYear
1
An infant with milky blood : an unusual but treatable case of familial hyperlipidemia. (24426212)
2013
2
Novel pharmacotherapies of familial hyperlipidemia. (23639874)
2013
3
Stress perfusion-fibrosis cardiac magnetic resonance detects early heart involvement in young asymptomatic, homozygous familial hyperlipidemia with normal routine non-invasive evaluation. (23896536)
2013
4
Low-density lipoprotein cholesterol, apolipoprotein B, and risk of coronary heart disease: from familial hyperlipidemia to genomics. (22531366)
2013
5
Diffuse involvement of aorta in patient with familial hyperlipidemia. (22347657)
2011
6
Supravalvular aortic stenosis secondary to severe lipid accumulation in the ascending aorta in a patient with uncontrolled familial hyperlipidemia. (21918328)
2011
7
Antihyperlipidemic agents cause a decrease in von Willebrand factor levels in pediatric patients with familial hyperlipidemia. (21073119)
2010
8
Pregnancy-induced severe gestational hyperlipidemia mimicking familial hyperlipidemia. (17097797)
2008
9
Association between physical activity, adiposity, and lipid abnormalities in children with familial hyperlipidemia. (17301628)
2007
10
Apolipoprotein B is associated with metabolic syndrome in Chinese pedigrees with familial hyperlipidemia]. (15854507)
2005
11
Micro- and macrocirculatory effects of apheresis in patients with familial hyperlipidemia. (12921126)
2003
12
A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemia. (12032266)
2002
13
Hypertriglyceridemia and plasma insulin in combined familial hyperlipidemia]. (9547191)
1997
14
Atypical pyloric stenosis in an infant with familial hyperlipidemia. (8657477)
1996
15
MR imaging of Achilles tendon in patients with familial hyperlipidemia: comparison with plain films, physical examination, and patients with traumatic tendon lesions. (7839978)
1995
16
Adult cardiologists or hyperlipidemia experts have advocated no screening and no treatment for children with familial hyperlipidemia. (8435922)
1993
17
Frequency and role of apo E phenotype in familial hypercholesterolemia and non-familial hyperlipidemia in the Japanese. (2375785)
1990
18
Familial hyperlipidemia in stroke in the young. (3810712)
1986
19
Changes of serum total cholesterol and triglyceride levels in normal subjects in Japan in the past twenty years. Research committee on familial hyperlipidemia in Japan. (6655789)
1983
20
Familial hyperlipidemia in coronary atherosclerotic heart disease. (6619068)
1983
21
Antithrombin functional activity after a fatty meal in normal subjects, familial hyperlipidemia, and nephrotic syndrome. (578151)
1977
22
Glycogen storage disease previously reported as familial hyperlipidemia. (5215216)
1965
23
THIN-LAYER CHROMATOGRAPHIC ANALYSIS OF PLASMA PHOSPHOLIPIDS IN ESSENTIAL FAMILIAL HYPERLIPIDEMIA. (14226394)
1964

Variations for Familial Hyperlipidemia

About this section

Expression for genes affiliated with Familial Hyperlipidemia

About this section
Sources:
2BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Familial Hyperlipidemia

Search GEO for disease gene expression data for Familial Hyperlipidemia.

Pathways for genes affiliated with Familial Hyperlipidemia

About this section
Sources:
50PathCards, 55Reactome, 30KEGG, 38NCBI BioSystems Database, 12EMD Millipore, 51PharmGKB
See all sources

Pathways related to Familial Hyperlipidemia according to GeneCards/GeneDecks:

(show all 13)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Show member pathways
9.0APOA1, APOB, APOE
2
Show member pathways
fatty acid beta-oxidation VI (peroxisome)38
8.9APOA1, APOA5, APOA2, LPL, APOC3
3
Show member pathways
thioredoxin pathway38
8.8APOB, LDLR, APOA1, INS
4
Show member pathways
8.8APOA1, APOA5, HMGCR, APOA2, LPL
5
Show member pathways
Vitamin B12 Metabolism38
8.7INS, APOE, APOA1
68.7APOB, APOA2, APOA1, LPA, INS
7
Show member pathways
8.5LPL, LDLR, INS, HMGCR
8
Show member pathways
7.4APOA1, APOE, APOC3, APOA2, APOC2, APOB
9
Show member pathways
6.8APOC3, APOA2, APOC2, LDLR, LPL, APOA1
106.8APOE, INS, APOB, APOA1, APOC3, APOA2
11
Show member pathways
5.8APOC2, APOB, LIPC, LDLR, CETP, LPA
12
Show member pathways
5.8APOB, CETP, APOC2, LIPC, LDLR, APOA2
13
Show member pathways
4.8APOC3, HMGCR, LCAT, LPL, LPA, CETP

Compounds for genes affiliated with Familial Hyperlipidemia

About this section
Sources:
45Novoseek, 29IUPHAR, 24HMDB, 11DrugBank, 51PharmGKB, 61Tocris Bioscience
See all sources

Compounds related to Familial Hyperlipidemia according to GeneCards/GeneDecks:

(show top 50)    (show all 450)
idCompoundScoreTop Affiliating Genes
1psyllium459.1LCAT, CETP, LDLR, HMGCR, APOB
2fenofibric acid45 299.9APOC3, APOA1, HMGCR, LPL, APOB
3colestipol458.9APOB, COG2, HMGCR, APOA1
4mspi458.8APOA1, APOC3, LPA, CETP, LDLR, APOB
5ciprofibrate45 299.6APOA1, APOB, LDLR, LPL, HMGCR
6acipimox45 299.6APOA1, INS, HMGCR, CETP, APOB
7lathosterol45 249.5CETP, LDLR, HMGCR, APOE, APOB
8sele458.4LDLR, APOE, CETP, APOC3, LPL
9dimyristoylphosphatidylcholine458.3LPA, LDLR, APOA2, APOA5, APOA1, APOE
10xbai458.2CETP, APOC3, LDLR, APOE, APOB, LPL
11ezetimibe45 119.0APOA1, INS, APOB, LDLR, CETP, HMGCR
12retinyl palmitate45 249.0APOA1, APOB, APOE, COG2, LPL, LCAT
13sodium dodecylsulfate457.8APOC2, CETP, LIPC, LPA, LPL, APOE
14homocysteine45 248.8LPA, CETP, APOB, APOC2, APOC3, APOA1
15ritonavir45 51 119.7LPL, APOC3, HMGCR, INS, APOE, LDLR
16cholestyramine457.6HMGCR, COG2, LPA, CETP, LDLR, APOB
17alpha tocopherol457.5LCAT, HMGCR, CETP, LDLR, APOB, LPL
18aspirin45 51 29 2410.4COG2, HMGCR, APOE, APOB, LPA, CETP
19fluvastatin45 51 29 1110.3CETP, LDLR, APOB, APOA1, APOE, LPL
20rosiglitazone29 45 51 24 1111.3COG2, INS, LPA, APOC3, APOE, LPL
21niacin45 118.2INS, APOA1, HMGCR, COG2, LPL, LPA
22fibrinogen457.2INS, APOA1, APOC3, APOA2, LIPC, COG2
23probucol45 118.1CETP, LDLR, LIPC, APOB, APOA1, APOE
24carbohydrates457.0CETP, LDLR, LPL, LIPC, APOC3, APOE
25rosuvastatin45 51 29 1110.0COG2, CETP, LDLR, APOB, APOC3, APOA1
26phosphatidylcholine456.9LIPC, APOB, APOA2, APOA1, APOE, LDLR
27palmitate456.8INS, APOE, APOA1, COG2, LCAT, LPL
28intralipid456.8LCAT, LPL, CETP, LIPC, APOB, APOA2
29creatinine456.7INS, APOA1, APOC3, HMGCR, COG2, LPA
30vitamin a45 24 118.7LCAT, LPL, LPA, CETP, LDLR, LIPC
31sterol456.7HMGCR, PCSK9, COG2, LCAT, CETP, LDLR
32glucose456.6APOA5, COG2, APOA2, APOB, APOC3, APOA1
33pravastatin45 51 29 24 1110.5LCAT, LPL, LPA, CETP, LDLR, APOB
34simvastatin45 51 61 29 24 1111.5APOE, HMGCR, COG2, LCAT, LPL, LPA
35phospholipid456.2LPL, COG2, LCAT, CETP, LDLR, LIPC
36lovastatin45 51 61 29 1110.1APOA5, APOC3, APOA1, APOE, APOB, HMGCR
37testosterone45 61 24 119.0CETP, LIPC, APOE, APOA1, APOC3, COG2
38fatty acid456.0LCAT, LPL, LPA, CETP, COG2, LDLR
39serine456.0INS, APOE, APOA1, APOB, APOC2, APOA2
40thyroxine45 246.9APOB, APOA1, APOE, INS, LDLR, HMGCR
41cholesterol ester455.8APOE, APOA1, APOC3, APOA2, HMGCR, COG2
42atorvastatin45 51 29 24 119.8HMGCR, COG2, LCAT, LPL, LPA, CETP
43heparin45 29 24 118.6APOC3, APOE, APOA5, APOA2, LCAT, LPL
44triacylglycerol455.4LCAT, LPL, CETP, LDLR, LIPC, APOB
45estrogen455.3LDLR, COG2, LCAT, LPL, LPA, CETP
46gemfibrozil29 45 117.3HMGCR, COG2, INS, APOE, LPL, LPA
47fenofibrate45 51 117.2HMGCR, COG2, LPL, LPA, CETP, LDLR
48bezafibrate45 29 117.2APOC3, APOA1, APOE, INS, APOA2, APOB
49cholesterol45 29 24 117.3COG2, HMGCR, PCSK9, APOA1, APOC3, APOA2
50lipid454.2APOE, USF1, INS, APOA1, APOC3, APOA5

GO Terms for genes affiliated with Familial Hyperlipidemia

About this section
Sources:
16Gene Ontology
See all sources

Cellular components related to Familial Hyperlipidemia according to GeneCards/GeneDecks:

(show all 15)
idNameGO IDScoreTop Affiliating Genes
1spherical high-density lipoprotein particleGO:0343669.6APOA1, APOC3, APOA2, APOC2
2endosome lumenGO:0319049.5APOB, INS
3secretory granule lumenGO:0347749.5APOA1, INS
4extrinsic component of external side of plasma membraneGO:0312329.3APOE, PCSK9
5endocytic vesicle lumenGO:0716829.1APOB, APOA1, APOE
6intermediate-density lipoprotein particleGO:0343639.1APOE, APOC3, APOC2, APOB
7endoplasmic reticulum lumenGO:0057889.0INS, APOA1, APOA2, APOB
8late endosomeGO:0057708.7PCSK9, LDLR, APOE
9low-density lipoprotein particleGO:0343628.7APOE, APOA5, APOC2, APOB, LDLR
10chylomicronGO:0426278.2LPL, APOB, APOC2, APOA2, APOA5, APOC3
11high-density lipoprotein particleGO:0343648.1APOA1, APOE, APOA5, APOA2, LIPC, LCAT
12early endosomeGO:0057697.9APOE, APOA1, APOC3, APOA2, APOC2, APOB
13very-low-density lipoprotein particleGO:0343617.8LPL, APOB, APOC2, APOA2, APOA5, APOC3
14extracellular regionGO:0055766.3INS, APOE, APOA1, APOC3, APOA5, APOA2
15extracellular spaceGO:0056156.1APOA5, APOC3, APOA1, APOE, INS, APOC2

Biological processes related to Familial Hyperlipidemia according to GeneCards/GeneDecks:

(show top 50)    (show all 61)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of cholesterol importGO:06062110.4APOC3, APOA2
2positive regulation of very-low-density lipoprotein particle remodelingGO:01090210.3APOA5, APOC2
3negative regulation of cholesterol transportGO:03237510.3APOA2, APOC2
4negative regulation of lipid metabolic processGO:04583310.3APOC2, APOC3
5negative regulation of lipase activityGO:06019210.2APOA1, APOA2
6negative regulation of very-low-density lipoprotein particle clearanceGO:01091610.2APOC2, APOC3
7triglyceride-rich lipoprotein particle remodelingGO:03437010.2APOA5, APOA2, APOC2
8negative regulation of low-density lipoprotein particle clearanceGO:01098910.2PCSK9, APOC3
9positive regulation of lipid catabolic processGO:05099610.1APOA5, APOA2
10regulation of intestinal cholesterol absorptionGO:03030010.1APOA1, APOA2
11negative regulation of very-low-density lipoprotein particle remodelingGO:01090310.1APOA1, APOC3, APOA2
12lipoprotein transportGO:04295310.1APOC3, APOC2, APOB
13cholesterol importGO:07050810.0APOA1, LDLR
14chylomicron remodelingGO:03437110.0APOC2, LPL
15positive regulation of triglyceride catabolic processGO:01089810.0APOC2, APOA5
16protein oxidationGO:01815810.0APOA1, APOA2
17phosphatidylcholine biosynthetic processGO:00665610.0LCAT, APOA2, APOA1
18organ regenerationGO:0311009.9APOA1, APOA5, APOA2
19lipid transportGO:0068699.9LPA, CETP, APOA5
20triglyceride mobilizationGO:0066429.8APOC3, APOB
21negative regulation of lipid catabolic processGO:0509959.8INS, APOC3, APOA2
22negative regulation of vasodilationGO:0459089.7HMGCR, INS
23negative regulation of cytokine secretion involved in immune responseGO:0027409.6APOA1, APOA2
24cellular lipid metabolic processGO:0442559.6HMGCR, APOA2, APOA5, APOA1
25high-density lipoprotein particle assemblyGO:0343809.5APOA2, APOA1, APOE
26positive regulation of cholesterol esterificationGO:0108739.5APOE, APOA1, APOA2
27regulation of Cdc42 protein signal transductionGO:0324899.5APOE, APOA1, APOC3
28peripheral nervous system axon regenerationGO:0140129.3APOE, APOA1
29lipoprotein catabolic processGO:0421599.3APOE, APOB, LDLR
30response to drugGO:0424939.3APOA1, APOC3, APOA2, APOC2, LPL
31high-density lipoprotein particle clearanceGO:0343849.3APOE, APOA1, APOA2, APOC2
32cholesterol transportGO:0303019.3APOA1, APOB, LDLR, CETP, LCAT
33chylomicron remnant clearanceGO:0343829.1APOE, APOC3, APOC2, LIPC
34lipoprotein biosynthetic processGO:0421589.1APOE, APOA1, APOB, LCAT
35triglyceride catabolic processGO:0194339.1APOC3, APOA5, APOB, LIPC, LPL
36phospholipid effluxGO:0337009.1APOE, APOA1, APOC3, APOA2, APOC2
37low-density lipoprotein particle remodelingGO:0343748.8CETP, LIPC, APOB, APOA2, APOE
38receptor-mediated endocytosisGO:0068988.7APOE, APOB, LDLR, CETP, LPA
39cholesterol effluxGO:0333448.7APOE, APOA1, APOC3, APOA2, APOC2, APOB
40triglyceride homeostasisGO:0703288.6LIPC, APOC2, APOA5, APOC3, APOA1, CETP
41triglyceride metabolic processGO:0066418.4PCSK9, LPL, CETP, APOA2, APOA5, APOC3
42very-low-density lipoprotein particle remodelingGO:0343728.3LCAT, LPL, CETP, LIPC, APOC2, APOE
43high-density lipoprotein particle remodelingGO:0343758.3APOE, LCAT, CETP, LIPC, APOA2, APOC3
44reverse cholesterol transportGO:0436918.1LCAT, CETP, LIPC, APOC2, APOA2, APOC3
45retinoid metabolic processGO:0015237.8LDLR, APOB, APOC2, APOA2, APOC3, APOA1
46phototransduction, visible lightGO:0076037.8APOE, APOA1, APOC3, APOA2, LPL, LDLR
47cholesterol metabolic processGO:0082037.3PCSK9, LCAT, CETP, LDLR, LIPC, APOB
48cholesterol homeostasisGO:0426326.8APOE, APOA1, PCSK9, LCAT, CETP, LDLR
49lipoprotein metabolic processGO:0421576.5PCSK9, LCAT, LPL, LPA, CETP, LDLR
50small molecule metabolic processGO:0442815.7HMGCR, INS, APOE, APOA1, LCAT, LPL

Molecular functions related to Familial Hyperlipidemia according to GeneCards/GeneDecks:

(show all 23)
idNameGO IDScoreTop Affiliating Genes
1lipoprotein lipase activator activityGO:06023010.2APOC2, APOA5
2high-density lipoprotein particle receptor bindingGO:07065310.0APOA1, APOC3, APOA2
3phosphatidylcholine bindingGO:03121010.0CETP, APOA2, APOA5
4apolipoprotein receptor bindingGO:03419010.0APOA1, APOA2, PCSK9
5lipase bindingGO:03547310.0APOA5, APOB
6high-density lipoprotein particle bindingGO:0080359.9APOA2, APOA1
7triglyceride bindingGO:0171299.9LPL, CETP
8phospholipid transporter activityGO:0055489.9CETP, APOA1
9lipase inhibitor activityGO:0551029.8APOA1, APOC3, APOA2, APOC2
10cholesterol bindingGO:0154859.7APOA1, APOC3, APOA2, CETP
11low-density lipoprotein particle bindingGO:0301699.6LIPC, LDLR, PCSK9
12very-low-density lipoprotein particle receptor bindingGO:0703269.5PCSK9, APOE
13phospholipase activityGO:0046209.4LPL, LIPC
14lipid transporter activityGO:0053199.4APOE, APOA2, CETP
15phosphatidylcholine-sterol O-acyltransferase activator activityGO:0602289.4APOA2, APOA1, APOE
16apolipoprotein bindingGO:0341859.3PCSK9, LPL, LPA, LIPC
17low-density lipoprotein particle receptor bindingGO:0507509.2APOE, APOA5, APOB, PCSK9
18lipid bindingGO:0082899.0APOE, APOA5, APOA2, APOC2, CETP
19cholesterol transporter activityGO:0171278.9CETP, APOB, APOA2, APOA1, APOE
20phospholipid bindingGO:0055438.6APOE, APOA1, APOC3, APOA5, APOA2, APOB
21protein homodimerization activityGO:0428038.3USF1, APOE, APOA2, APOC2, HMGCR
22heparin bindingGO:0082018.1APOE, APOA5, APOB, LIPC, LPA, LPL
23protein bindingGO:0055155.8APOA2, APOA1, APOE, USF1, INS, APOB

Products for genes affiliated with Familial Hyperlipidemia

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Familial Hyperlipidemia

About this section
4CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
29IUPHAR
30KEGG
35MeSH
36MESH via Orphanet
37MGI
40NCIt
41NDF-RT
44NINDS
45Novoseek
47OMIM
48OMIM via Orphanet
52PubMed
53QIAGEN
59SNOMED-CT via Orphanet
62UMLS
63UMLS via Orphanet